Colony-stimulating factor 1 receptor (CSF1R) signaling in injured neurons facilitates protection and survival

Colony-stimulating factor 1 and IL-34 protect against and partially reverse neurodegeneration in mice in part via promoting CREB signaling.

[1]  J. Hamilton,et al.  Colony stimulating factors and myeloid cell biology in health and disease. , 2013, Trends in immunology.

[2]  M. Mehler,et al.  The CSF-1 receptor ligands IL-34 and CSF-1 exhibit distinct developmental brain expression patterns and regulate neural progenitor cell maintenance and maturation. , 2012, Developmental biology.

[3]  L. Williams,et al.  The mechanism of shared but distinct CSF-1R signaling by the non-homologous cytokines IL-34 and CSF-1. , 2012, Biochimica et biophysica acta.

[4]  M. Diamond,et al.  IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia , 2012, Nature Immunology.

[5]  D. Hume,et al.  Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. , 2012, Blood.

[6]  J. Pollard,et al.  Absence of Colony Stimulation Factor-1 Receptor Results in Loss of Microglia, Disrupted Brain Development and Olfactory Deficits , 2011, PloS one.

[7]  H. Mizoguchi,et al.  Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity. , 2011, The American journal of pathology.

[8]  K. Rufibach,et al.  Modeling of Pathological Traits in Alzheimer's Disease Based on Systemic Extracellular Signaling Proteome* , 2011, Molecular & Cellular Proteomics.

[9]  S. Okada,et al.  IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation , 2010, Cell Death and Differentiation.

[10]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[11]  L. Williams,et al.  Functional overlap but differential expression of CSF‐1 and IL‐34 in their CSF‐1 receptor‐mediated regulation of myeloid cells , 2010, Journal of leukocyte biology.

[12]  D. Hume,et al.  Pivotal Advance: Avian colony‐stimulating factor 1 (CSF‐1), interleukin‐34 (IL‐34), and CSF‐1 receptor genes and gene products , 2010, Journal of leukocyte biology.

[13]  J. Julien,et al.  Macrophage colony stimulating factor (M-CSF) exacerbates ALS disease in a mouse model through altered responses of microglia expressing mutant superoxide dismutase , 2009, Experimental Neurology.

[14]  T. Wyss-Coray,et al.  The p75 Neurotrophin Receptor Promotes Amyloid-β(1-42)-Induced Neuritic Dystrophy In Vitro and In Vivo , 2009, The Journal of Neuroscience.

[15]  A. Celada,et al.  CREB and AP‐1 activation regulates MKP‐1 induction by LPS or M‐CSF and their kinetics correlate with macrophage activation versus proliferation , 2009, European journal of immunology.

[16]  O. Arancio,et al.  Small Molecule, Non-Peptide p75NTR Ligands Inhibit Aβ-Induced Neurodegeneration and Synaptic Impairment , 2008, PloS one.

[17]  M. Myers,et al.  Macrophage colony stimulating factor: not just for macrophages anymore! A gateway into complex biologies. , 2008, International immunopharmacology.

[18]  J. Hamilton.  Colony-stimulating factors in inflammation and autoimmunity , 2008, Nature Reviews Immunology.

[19]  E. Masliah,et al.  The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. , 2008, The Journal of clinical investigation.

[20]  W. Schäbitz,et al.  Old friends in new constellations--the hematopoetic growth factors G-CSF, GM-CSF, and EPO for the treatment of neurological diseases. , 2008, Current medicinal chemistry.

[21]  J. Relton,et al.  Powerful beneficial effects of macrophage colony-stimulating factor on beta-amyloid deposition and cognitive impairment in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[22]  L. Williams,et al.  Discovery of a Cytokine and Its Receptor by Functional Screening of the Extracellular Proteome , 2008, Science.

[23]  F. Rossi,et al.  Local self-renewal can sustain CNS microglia maintenance and function throughout adult life , 2007, Nature Neuroscience.

[24]  S. Gambhir,et al.  Glia-dependent TGF-beta signaling, acting independently of the TH17 pathway, is critical for initiation of murine autoimmune encephalomyelitis. , 2007, The Journal of clinical investigation.

[25]  R. Tibshirani,et al.  Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins , 2007, Nature Medicine.

[26]  L. Luo,et al.  A global double‐fluorescent Cre reporter mouse , 2007, Genesis.

[27]  F. Maxfield,et al.  Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. , 2007, Molecular biology of the cell.

[28]  B. McEwen,et al.  Microglia derived from aging mice exhibit an altered inflammatory profile , 2007, Glia.

[29]  Tony Wyss-Coray,et al.  Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration , 2006, Proceedings of the National Academy of Sciences.

[30]  J. Pollard,et al.  Microarray analysis of uterine epithelial gene expression during the implantation window in the mouse. , 2006, Endocrinology.

[31]  Tony Wyss-Coray,et al.  Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.

[32]  M. Fornerod,et al.  Characterization of the Drosophila melanogaster genome at the nuclear lamina , 2006, Nature Genetics.

[33]  J. Pollard,et al.  Conditional deletion of the colony stimulating factor‐1 receptor (c‐fms proto‐oncogene) in mice , 2006, Genesis.

[34]  E. Stanley,et al.  Colony-stimulating factor-1 in immunity and inflammation. , 2006, Current opinion in immunology.

[35]  J. Parham,et al.  Inhibition of colony-stimulating-factor-1 signaling in vivo with the orally bioavailable cFMS kinase inhibitor GW2580. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Christopher H Contag,et al.  Global Analysis of Smad2/3-Dependent TGF-β Signaling in Living Mice Reveals Prominent Tissue-Specific Responses to Injury1 , 2005, The Journal of Immunology.

[37]  Victoria M Perreau,et al.  Voluntary Exercise Decreases Amyloid Load in a Transgenic Model of Alzheimer's Disease , 2005, The Journal of Neuroscience.

[38]  F. Pixley,et al.  CSF-1 regulation of the wandering macrophage: complexity in action. , 2004, Trends in cell biology.

[39]  A. Tenner,et al.  Macrophage colony stimulatory factor and interferon‐γ trigger distinct mechanisms for augmentation of β‐amyloid‐induced microglia‐mediated neurotoxicity , 2004 .

[40]  Lingyun Zhu,et al.  Non-invasive imaging of GFAP expression after neuronal damage in mice , 2004, Neuroscience Letters.

[41]  M. Mattson.  Pathways towards and away from Alzheimer's disease , 2004, Nature.

[42]  Jiayou Zhang,et al.  Conditional macrophage ablation in transgenic mice expressing a Fas‐based suicide gene , 2004, Journal of leukocyte biology.

[43]  C. Verney,et al.  Early microglial activation following neonatal excitotoxic brain damage in mice: a potential target for neuroprotection , 2003, Neuroscience.

[44]  Y. Imai,et al.  Intracellular signaling in M‐CSF‐induced microglia activation: Role of Iba1 , 2002, Glia.

[45]  ChristopherC . Robinson,et al.  Macrophage colony stimulating factor prevents NMDA‐induced neuronal death in hippocampal organotypic cultures , 2002, Journal of neurochemistry.

[46]  D. Ginty,et al.  Function and Regulation of CREB Family Transcription Factors in the Nervous System , 2002, Neuron.

[47]  J. Hidalgo,et al.  RETRACTED: M-CSF Deficiency Leads to Reduced Metallothioneins I and II Expression and Increased Tissue Damage in the Brain Stem after 6-Aminonicotinamide Treatment , 2002, Experimental Neurology.

[48]  B. Puig,et al.  Active, phosphorylation-dependent MAP kinases, MAPK/ERK, SAPK/JNK and p38, and specific transcription factor substrates are differentially expressed following systemic administration of kainic acid to the adult rat , 2002, Acta Neuropathologica.

[49]  M. Mallory,et al.  Early formation of mature amyloid‐β protein deposits in a mutant APP transgenic model depends on levels of Aβ1–42 , 2001, Journal of neuroscience research.

[50]  E. Kandel.  The Molecular Biology of Memory Storage: A Dialogue Between Genes and Synapses , 2001, Science.

[51]  K. Kiuchi,et al.  Macrophage colony‐stimulating factor is expressed in neuron and microglia after focal brain injury , 2001, Journal of neuroscience research.

[52]  J. Pollard,et al.  Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. , 2001, Blood.

[53]  Shankar Srinivas,et al.  Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus , 2001, BMC Developmental Biology.

[54]  R. Jaenisch,et al.  DNA Hypomethylation Perturbs the Function and Survival of CNS Neurons in Postnatal Animals , 2001, The Journal of Neuroscience.

[55]  G. Murphy,et al.  Expression of macrophage colony-stimulating factor receptor is increased in the AbetaPP(V717F) transgenic mouse model of Alzheimer's disease. , 2000, The American journal of pathology.

[56]  M. Dragunow,et al.  Is CREB a key to neuronal survival? , 2000, Trends in Neurosciences.

[57]  O. Berezovska,et al.  Expression of colony stimulating factor‐1 receptor (CSF‐1R) by CNS neurons in mice , 1999, Journal of neuroscience research.

[58]  S. Murase,et al.  Expression Pattern and Neurotrophic Role of the c-fms Proto-Oncogene M-CSF Receptor in Rodent Purkinje Cells , 1998, The Journal of Neuroscience.

[59]  G. Murphy,et al.  Macrophage Colony-stimulating Factor Augments β-Amyloid-induced Interleukin-1, Interleukin-6, and Nitric Oxide Production by Microglial Cells* , 1998, The Journal of Biological Chemistry.

[60]  G. Kreutzberg,et al.  Regulation of MSCF receptors on microglia in the normal and injured mouse central nervous system: A quantitative immunofluorescence study using confocal laser microscopy , 1998, The Journal of comparative neurology.

[61]  J. McNamara,et al.  A Point Mutation (D79N) of the α2A Adrenergic Receptor Abolishes the Antiepileptogenic Action of Endogenous Norepinephrine , 1998, The Journal of Neuroscience.

[62]  J. Hamilton.  CSF‐1 signal transduction , 1997, Journal of leukocyte biology.

[63]  Tomoko Nakanishi,et al.  ‘Green mice’ as a source of ubiquitous green cells , 1997, FEBS letters.

[64]  D. Maysinger,et al.  Colony stimulating factor-1 potentiates neuronal survival in cerebral cortex ischemic lesion , 1996, Acta Neuropathologica.

[65]  M. Michaelson,et al.  CSF-1 deficiency in mice results in abnormal brain development. , 1996, Development.

[66]  D. Maysinger,et al.  The hematopoietic cytokine, colony-stimulating factor 1, is also a growth factor in the CNS: Congenital absence of CSF-1 in mice results in abnormal microglial response and increased neuron vulnerability to injury , 1995, International Journal of Developmental Neuroscience.

[67]  F. Pont,et al.  Early and transient increase of rat hippocampal blood-brain barrier permeability to amino acids during kainic acid-induced seizures , 1995, Neuroscience Letters.

[68]  T. Marunouchi,et al.  Expression of cytokine receptors in cultured neuronal and glial cells , 1993, Neuroscience Letters.

[69]  J. Nemunaitis,et al.  Long-term follow-up of patients with invasive fungal disease who received adjunctive therapy with recombinant human macrophage colony-stimulating factor. , 1993, Blood.

[70]  W. Wiktor-Jedrzejczak,et al.  Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[71]  S. Nishikawa,et al.  The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.

[72]  Rohrschneider Lr,et al.  Murine c-fms cDNA: cloning, sequence analysis and retroviral expression. , 1987 .

[73]  Charles J. Sherr,et al.  The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF 1 , 1985, Cell.

[74]  J. Kaye,et al.  The ageing systemic milieu negatively regulates neurogenesis and cognitive function , 2011 .

[75]  Andrew V. Nguyen,et al.  Tumorigenesis and Neoplastic Progression A Novel Mouse Model of Inflammatory Bowel Disease Links Mammalian Target of Rapamycin-Dependent Hyperproliferation of Colonic Epithelium to Inflammation-Associated Tumorigenesis , 2010 .

[76]  A. Tenner,et al.  Macrophage colony stimulatory factor and interferon-gamma trigger distinct mechanisms for augmentation of beta-amyloid-induced microglia-mediated neurotoxicity. , 2004, Journal of neurochemistry.

[77]  R. Russell,et al.  Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mononuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. , 2002, Blood.

[78]  L. Macmillan,et al.  A point mutation (D79N) of the alpha2A adrenergic receptor abolishes the antiepileptogenic action of endogenous norepinephrine. , 1998, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[79]  X. Chen,et al.  Amyloid- (cid:98) peptide–Receptor for Advanced Glycation Endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: A proinflammatory pathway in Alzheimer disease , 1997 .

[80]  Jane A. Langdale,et al.  In situ Hybridization , 1994 .

[81]  G. Santoro,et al.  Blood-brain barrier dysfunctions following systemic injection of kainic acid in the rat. , 1992, Life sciences.

[82]  L. Rohrschneider,et al.  Murine c-fms cDNA: cloning, sequence analysis and retroviral expression. , 1987, Oncogene research.